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Objectives: To evaluate early and late results of carotid endarterectomy (CEA) in female patients in a large single center
experience.
Methods: Over a 12-year period ending in December 2007, 4009 consecutive primary and secondary CEAs in 3324
patients were performed at our institution. All patients were prospectively enrolled in a dedicated database containing
pre-, intra-, and postoperative parameters. Patients were female in 1200 cases (1020 patients; Group 1) and male in the
remaining 2809 (2304 patients, Group 2). Early results in terms of intraoperative neurological events and 30-day stroke
and death rates were analyzed and compared. Follow-up results were analyzed with Kaplan Meier curves and compared
with log-rank test.
Results: Patients of Group 1 were more likely to have hyperlipemia, diabetes, and hypertension; patients of Group 2
were more likely to be smokers and to have concomitant coronary artery disease (CAD) and peripheral arterial disease
(PAD). There were no differences in terms of clinical status or degree of stenosis. Patients of Group 2 had a
significantly higher percentage of contralateral carotid artery occlusion than patients in Group 1 (6.9% and 3.9%,
respectively; P < .001). Thirty-day stroke and death rates were similar in the two groups (1.2% for both groups).
Univariate analysis demonstrated the presence of CAD, PAD, diabetes, and contralateral carotid artery occlusion to
significantly affect 30-day stroke and death rate in female patients. At multivariate analysis, only diabetes (odds ratio
[OR] 3.6, 95% confidence interval [CI] 0.1-0.9; P  .05) and contralateral occlusion (OR 7.4, 95% CI 0.03-0.6;
P  .006) were independently associated with an increased perioperative risk of stroke and death. Median duration
of follow-up was 27 months (range, 1-144 months). There were no overall differences between the two groups in
terms of survival, freedom from ipsilateral stroke, freedom from any neurological symptom, and incidence of severe
(>70%) restenosis. In contrast to male patients, univariate and multivariate analysis demonstrated that female
patients with diabetes or contralateral occlusion had an increased risk of developing ipsilateral neurological events
during follow-up.
Conclusions: Female sex per se does not represent an adjunctive risk factor during CEA, with early and long term results
comparable to those obtained in male patients. However, in our study we found subgroups of female patients at higher
surgical risk, requiring careful intra- and postoperative management. (J Vasc Surg 2009;50:1301-7.)Carotid endarterectomy (CEA) is a safe and effective
procedure and still represents the best therapeutic option1
for the treatment of extracranial carotid artery disease. The
degree of benefit, however, is strongly related to the peri-
operative risk of death and neurological complications.
Currently, CEA can be performed with acceptable peri-
operative risks. In high-volume centers the 30-day overall
rate of stroke and death is typically under 3% in asymptom-
atic patients and under 5% in symptomatic patients, as
recommended by published guidelines.2 When periopera-
tive complication rates exceed these recommended limits,
the benefits of CEA are insignificant, particularly in asymp-
tomatic patients.
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tients at higher surgical risk seems to be necessary to allow
a proper selection of patients for surgical interventions.
Female gender has been reported by several authors to be a
risk factor for perioperative stroke and death after CEA;3-6
however, more recent studies reported contrary findings7-9
and there is a general lack of data concerning subgroup
analysis in female patients.
The aim of this study was to retrospectively analyze
early and long term results of CEA in female patients in our
single center experience, paying particular attention to
clinical, anatomical, and technical factors affecting peri-
operative and follow-up outcomes.
PATIENT POPULATION AND METHODS
From January 1996 to December 2007, 4009 consec-
utive CEAs in 3324 patients were performed at the Univer-
sity of Florence. In 540 cases bilateral intervention and in
145 reintervention were performed. Data concerning these
interventions were prospectively collected in a dedicated
database containing 150 fields, including anatomical, clin-
ical, diagnostic, and technical variables. This database also
contains perioperative (30 days) results in terms of mor-
tality and neurological morbidity and all relevant clinical
and diagnostic data collected during follow-up.
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performed and two subgroups of patients were identified:
female patients (1020 patients, 1200 interventions, Group
1) and male patients (2304 patients, 2809 interventions,
Group 2).
The two groups of patients were compared in terms of
demographic data, common risk factors for atherosclerosis,
and comorbidities. Clinical and anatomical indications for
surgery, intraoperative technical features, and perioperative
(30 days) results of interventions were analyzed in terms
of stroke and death with 2 test and Fisher’s exact test,
when necessary.
Risk factors and comorbidities included arterial hyper-
tension (defined as blood pressure greater than 130/80
mm Hg or the need for anti-hypertensive drugs), diabetes
mellitus (defined as the need for specific drugs), hyperli-
pemia (defined as triglycerides and cholesterol values200
mg/dL), coronary artery disease (history of myocardial
infarction, angina, previous coronary revascularization) and
peripheral arterial disease (ankle/brachial index0.9). Pa-
tients were considered to be asymptomatic in the absence of
neurological symptoms (transient ischemic attack [TIA] or
stroke) within six months from the intervention and the
degree of carotid stenosis was measured with North Amer-
ican Symptomatic Carotid Endarterectomy Trial (NASCET)
criteria. Duplex scan criteria suggested by the Italian Soci-
ety for Vascular Investigation were used for determining
the presence of significant carotid stenosis.10 Intraoperative
data included type of anesthesia, cerebral monitoring and
protection, and technique of carotid reconstruction.
Patients undergoing CEA under general anaesthesia
had cerebral monitoring with somatosensory evoked po-
tentials (SEPs) and selective shunt insertion on the basis of
SEP abnormalities.11
Univariate and multivariate analysis (stepwise logistic
regression) of the factors affecting early results in Group 1
were performed. Statistical significance was defined as a
P value less than 0.05.
Follow-up was performed at one, three, six, and 12
months and yearly thereafter by clinical examination and
duplex scan. All studies were performed using an Acuson
Sequoia 512 Ultrasound System (Acuson Corporation,
Mountain View, Calif). Neurologic evaluation at 30 days
was independently performed in all patients by an experi-
enced neurologist.
Follow-up data were analyzed by life-table analysis
(Kaplan-Meier test) in terms of stroke, death, and signifi-
cant (70%) restenosis and results in the two groups were
compared by means of log rank test. Univariate and multi-
variate analysis (Cox’s regression) of the factors affecting
late results in Group 1 were performed.
Statistical analysis was performed by means of SPSS
15.0 for Windows (SPSS Inc., Chicago, Ill).
RESULTS
Demographic data, risk factors, comorbidities, clin-
ical and anatomical status. There were significant differ-
ences between the two groups of patients in terms of demo-graphic data, risk factors, and comorbidities (Table I). Female
patients were older than males and were more likely to have
arterial hypertension, hyperlipemia, and diabetes. History of
smoking, coronary artery disease, and peripheral arterial dis-
ease were more common among males.
There were no differences between the two groups in
terms of clinical presentation, degree of carotid stenosis and
type of intervention (primary or secondary intervention),
while interventions in Group 2 were more likely to be
performed in patients with contralateral carotid artery se-
vere (70%) stenosis and occlusion (Table II).
Intraoperative details. Local anaesthesia was used in
345 interventions in Group 1 (29%) and in 827 patients in
Group 2 (30%; P n.s.). Also, the shunt insertion rate was
similar between the groups (11% in both groups, P n.s.).
There was a higher percentage of shunt insertion on the
basis of modifications of cerebral monitoring in patients
with contralateral occlusion, both in females (20% vs. 8.5%
in females without contralateral occlusion, P .007) and in
males (29% vs. 6.2% in males without contralateral occlu-
sion, P .001). Concerning arterial reconstruction, a wide
use of patch closure was noted in both groups (79% in
Group 1 and 74% in Group 2, P n.s.) ; patients in Group
Table I. Patients’ demographic data, risk factors, and
comorbidities
Group 1
(n  1020)
Group 2
(n  2304) P
Median age (yr) 72.3 71.3 .009
Age 79 yr 191 (16%) 389 (14%) .08
Hypercholesterolemia 518 (51%) 892 (39%) .001
Hypertrigliceridemia 329 (32%) 624 (27%) .002
Arterial hypertension 749 (73%) 1469 (64%) .001
Diabetes mellitus 225 (22%) 440 (19%) .04
Coronary artery disease 156 (15%) 530 (23%) .001
Peripheral artery disease 253 (25%) 755 (34%) .001
Smoker or past smoker 370 (36%) 1881 (81%) .001
Table II. Clinical and anatomical features
Group 1
(CEAs  1200)
Group 2
(CEAs  2809) P
Preoperative symptoms
TIA
Minor stroke
Major stroke
Vertebrobasilar
401 (34%) 999 (36%) n.s.
227 607
36 127
7 31
131 233
Asymptomatic patients 799 (66%) 1810 (64%) n.s.
Degree of stenosis
- 60-80%
- 80%
- Near-occlusion
509 (42%) 1145 (42%) n.s.
656 (55%) 1537 (55%) n.s.
35 (3%) 96 (3%) n.s.
Contralateral severe
(70%) stenosis
or occlusion 105 (8.5%) 318 (11%) .015
Contralateral occlusion 45 (4%) 194 (7%) .001
Redo surgery 36 (3%) 110 (4%) n.s.1 were more likely to have an eversion technique than
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while primary closure was more frequent in males than in
females (23% and 14%, respectively; P  .001).
Early results. Perioperative (30 days) results were
similar in the two groups, with a cumulative stroke and
death rate of 1.2% in both groups (Table III).
Also the rates of postoperative acute myocardial infarc-
tions were similar in the two groups (five cases in Group 1,
0.5%, and 10 cases in Group 2, 0.4%; P  n.s.).
Univariate analysis of 30-day stroke and death rates in
females demonstrated that the presence of coronary artery
disease, peripheral arterial disease, diabetes, and contralat-
eral carotid artery occlusion significantly affected outcome
(Table IV). At multivariate analysis, however, only diabetes
(odds ratio [OR] 3.6, 95% confidence interval [CI] 0.1-
0.9; P .05) and contralateral occlusion (OR 7.4, 95% CI
0.03-0.6; P .006) were independently associated with an
increased perioperative risk of stroke and death.
The same analysis in male patients demonstrated that
only diabetes significantly affected 30-day stroke and death
rate at univariate analysis (P  .04).
A separate analysis for both stroke and death in female
patients demonstrated that diabetes significantly affected
both outcomes, with a 30-day stroke rate in diabetic fe-
males of 1.1% and in non diabetic females of 0.5% (P .05)
and corresponding values for 30-day death rate of 1.4% and
0.3%, respectively (P  .03). The presence of contralateral
occlusion significantly affected 30-day stroke rate (6.6% in
females with contralateral occlusion and 0.5% in females
without contralateral occlusion; P  .001) but not 30-day
death rate (0.5% in patients without contralateral occlusion,
while no death occurred in patients with contralateral oc-
clusion, P  n.s.).
The presence of contralateral occlusion significantly
affected 30-day stroke and death rate in symptomatic fe-
males (13.3% in patients with contralateral occlusion and
1.2% in patients without contralateral occlusion; P .001),
while in asymptomatic females only diabetes affected early
stroke and death rates (2.7% in diabetics and 0.3% in non
diabetics, P  .002).
Cumulative 30-day stroke and death rates in female
patients without diabetes and contralateral occlusion (891
Table III. Perioperative (30 days) results
Group 1
(n  1200)
Group 2
(n  2809) P
TIA 5 (0.4%) 17 (0.6%) n.s.
Stroke
Minor stroke
Major stroke
Fatal stroke
5 (0.4%) 14 (0.5%) n.s.
3 (0.2%) 4 (0.15%) n.s.
1 (0.1%) 4 (0.15%) n.s.
Death
- Neurological death
- Non neurological death
1 (0.1%) 4 (0.15%) n.s.
5 (0.4%) 11 (0.35%) n.s.
30-day stroke and death rate 14 (1.2%) 33 (1.2%) n.s.
TIA, Transient ischemic attack.patients) was 0.5%; the corresponding figures in femaleswith diabetes or contralateral occlusion (300 patients) and
in females with diabetes and contralateral occlusion (nine
patients) were 2.6% and 11.1%, respectively.
Follow-up results. Follow-up was available for 3348
patients (84% of the study group) for a mean duration of 27
months (range, 1-144 months). During follow-up, 67
deaths, 34 ipsilateral and contralateral neurological events,
and 94 severe (70%) restenoses were recorded.
Fifteen late deaths occurred in Group 1 and 52 in Group
2; in Group 1 the cause of late deaths was cancer in three
cases, cardiac disease in three cases, ischemic stroke in three
cases, cerebral hemorrhage in two cases, ruptured abdom-
inal aortic aneurysm in one case, and unknown in the
remaining three cases. Amongmales, the cause of death was
cardiac disease in 25 patients, cancer in seven cases, respi-
ratory insufficiency in three cases, ischemic stroke in three
cases, chronic renal failure in one case, ruptured abdominal
aortic aneurysm in one case, and unknown in the remaining
12 patients.
Cumulative estimated 48-month survival, freedom
from ipsilateral stroke, and freedom from severe restenosis
rates were 96%, 98%, and 95%, respectively.
There were no differences between Groups 1 and 2 in
terms of estimated 48-month survival (97.4% and 95.6%,
respectively; log rank 2.2, P  .1), freedom from any
ipsilateral and contralateral neurological event (97.8% for
Table IV. Univariate analysis for 30-day stroke and
death rate in female gender
30 day stroke
and death rate P
Age 79 yrs.
Age 79 yrs.
CAD
No CAD
PAD
No PAD
Arterial hypertension
No arterial hypertension
Diabetes
No diabetes
Contralateral severe (70%)
stenosis or occlusion
No contralateral severe disease
Contralateral occlusion
No contralateral occlusion
Symptomatic
Asymptomatic
13/1010 (1.2%) n.s.
1/190 (0.5%)
8/1011 (0.8%) .05
7/305 (2.2%)
7/895 (0.8%) .03
11/889 (1.2%)
3/311 (1%) n.s.
7/271 (2.6%)
7/929 (0.8%) .015
3/105 (2.8%) n.s.
11/1095 (1%)
3/45 (6.7%)
11/1155 (1.1%) .001
7/401 (1.7%)
7/799 (0.9%) n.s.
Preoperative TIA
Preoperative stroke
Vertebrobasilar symptoms
Local anaesthesia
General anaesthesia
Shunt insertion
No shunt insertion
Patch closure
No patch closure
4/227 (1.7%)
2/43 (4.6%)
1/131 (0.8%) n.s.
1/345 (0.4%)
13/855 (1.4%) n.s.
4/133 (3%)
10/1067 (1%) n.s.
11/959 (1.1%)
3/251 (1.2%) n.s.
CAD, Coronary artery disease; PAD, peripheral artery disease; TIA, tran-
sient ischemic attack.both groups; log rank 1.3, P .6), freedom from ipsilateral
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.5), and freedom from severe restenosis (93.8% and 96%,
respectively; log rank 0.6, P  .2).
In females, only four severe restenoses were associated
with the development of late neurological events (three
transient ischemic attacks and one major stroke).
Univariate analysis for the risk of any ipsilateral neuro-
logical event at 48 months in Group 1 again demonstrated
that the presence of diabetes (P .05, log rank 3.8) and of
contralateral carotid occlusion (P  .001, log rank 18.8)
were associated with poorer outcomes (Table V). These
findings were confirmed by Cox’s regression analysis (OR
3.7, 95% CI 0.13-1, P .05 for diabetes and OR 6.3, 95%
CI 0.03-0.7, P  .001 for contralateral occlusion). The
same analysis in male patients failed to identify any factors
affecting follow-up results.
DISCUSSION
Carotid endarterectomy continues to be the gold stan-
dard in the treatment of significant carotid artery stenosis
and has been shown to reduce the risk of stroke in selected
symptomatic and asymptomatic patients. Randomized tri-
als, including the North American Symptomatic Carotid
Endarterectomy Trial (NASCET),12 Asymptomatic Carotid
Atherosclerosis Study (ACAS),13 the European Carotid Sur-
gery Trial (ECST),14 and the Asymptomatic Carotid Surgery
Trial (ACST),15 resulted in a significant increase in the utili-
zation of CEA for stroke prevention. Unfortunately, these
trials are not without criticism, and subgroup analyses of these
and other trials have questioned the benefit of CEA in certain
high-risk patient populations such as increased patient age,
diabetes, renal insufficiency, and female gender.
In respect to female gender, each of the four large
randomized CEA trials demonstrated a lesser degree of
benefit for women compared with men undergoing carotid
endarterectomy. The ACAS trial demonstrated a significant
Table V. Univariate analysis for 48-month risk of
ipsilateral neurological event in female gender
(%) Log-rank P
No diabetes 98.9
Diabetes 92.5 3.8 .05
Age 79 yr 98.4
Age 79 yr 98.6 0.6 n.s.
CAD 96.7
No CAD 98 1.6 n.s.
Contralateral occlusion 90.1
No contralateral occlusion 98.2 18.8 .001
Symptomatic 97.8
Asymptomatic 97.9 2.1 n.s.
Patch closure 98.3
No patch closure 96 0.9 n.s.
Hyperlipemia 98.2
No hyperlipemia 97.5 0.02 n.s.
Arterial hypertension 98.5
No arterial hypertension 96.1 0.2 n.s.
CAD, Coronary artery disease.five-year reduction in stroke risk in men following CEA,but not in women (66% vs 17%). A majority of this differ-
ence is attributable to the higher perioperative stroke and
death rate for women (3.6%) versus men (1.7%). In fact, in
the ACAS trial, when perioperative events are removed
from long-term analysis, the five-year relative risk reduction
improved threefold to 56% for women and increased to
79% for men. The ACST study15 also reported only a 1.25%
annual reduction of stroke risk in women with a 3.7%
perioperative stroke risk. Post hoc analysis of the NASCET
results suggested that CEA may not be as beneficial for
women who are symptomatic with a 50% to 69% stenosis
because of a lower stroke risk in women randomized to
undergo medical management. Finally, the ECST trial of
symptomatic patients noted less benefit of CEA in women
due to higher perioperative risk and a 29% lower risk of
stroke with medical management.
More recent large retrospective trials have reported
conflicting results regarding the benefit and risk of CEA in
women. Akbari et al7 reported on their series of 1298 CEA
procedures of whom 520 (40%) were women and noted a
postoperative stroke rate of 1.2% in women and 1.7% in
men. They concluded that female gender is not a risk factor
for stroke, death, or cardiac morbidity after CEA. Mattos
and colleagues8 found in 1204 CEA procedures of whom
464 (39%) were women, that female gender did not affect
early or late survival, freedom from stroke, or stroke-free
death rates after CEA, and similar conclusions were recently
reported in the New York Carotid Artery Surgery Study.16
In contrast, Sarac and colleagues6 from the Cleveland
Clinic noted in a review of 3422 CEAs including 1148
female patients, that perioperative stroke and mortality
rates were increased in asymptomatic women (3.1% women
versus 2.1% for men, P .03).
Our data failed to find significant overall differences in
terms of early and long-term outcomes between males and
females. These results were obtained despite significant
differences in patient comorbidities between men and
women, as noted by other authors. Similar to our study,
Akbari et al7 and Mattos et al8 both noted that women had
a higher incidence of diabetes and HTN, while men were
more likely to have a smoking history and CAD. Our study
also evaluated the incidence of PAD and presence of con-
tralateral carotid occlusion and noted a predominance of
both in men compared with women (35% and 7% in men
versus 25% and 4%). We did not find any differences be-
tween men and women in terms of clinical presentation, in
spite of described gender-associated differences in carotid
plaques, suggesting more stable lesions in females than in
males.17
Subgroup analysis in the current study demonstrated
that with multivariate analysis, diabetes and contralateral
carotid occlusion significantly increased the 30-day stroke
and death rate in women. Overall stroke and death rate was
1.2% in females; however, this increased to 2.6% in the 25%
of female patients with diabetes or contralateral occlusion,
which remains within the suggested limits, and to 11.1% in
females with diabetes and contralateral carotid occlusion,
even if, with the limited number of patients and of events in
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mendation or definitive conclusion.
Diabetes has already been described by several au-
thors16,18,19 as a factor significantly affecting the results of
CEA, and it was not surprising that in the present study it
was found to increase perioperative risk also in male pa-
tients. Carotid plaques in diabetic patients are described to
have a higher prevalence of unstable features than plaques
from non-diabetics,20 which may explain the increased
perioperative risk of diabetics.
On the contrary, several studies have demonstrated that
the presence of contralateral carotid artery occlusion was
not associated with a significant increase in perioperative
risk of stroke and death.21,22 However, in our study, fe-
males with contralateral occlusion were found to have
higher perioperative stroke rates than both females without
contralateral occlusion and males with contralateral occlu-
sion, even if the number of females with contralateral
occlusion and the number of events in this subgroup is
quite small, limiting the statistical significance of this
finding. It is difficult to explain why in our series con-
tralateral carotid occlusion could have such a significant
impact in women; possibly, a diminished collateral blood
flow capacity in smaller vessels, such as in females with
contralateral occlusion, may in someway increase the risk of
neurological events both in the perioperative period and
during follow-up.
To our knowledge, there is only one published study23
reporting results similar to ours; however, in that series
contralateral carotid disease was considered as a unique
entity, without separate analyses for occlusion and stenosis.
In our study, no influence of contralateral severe stenosis
was found, and only the presence of contralateral occlusion
seemed to affect early and late results.
We did not find any difference in 30-day results in
terms of clinical presentation, with perioperative risk similar
between symptomatic and asymptomatic females. Symp-
tomatic women had a higher perioperative risk in the
presence of contralateral occlusion, but again this result can
be influenced by the limited number of patients and events
in these subgroup; asymptomatic diabetic patients had a
higher percentage of perioperative complications than
their non-diabetic counterparts, however, with a risk rate
below the recommended 3% level, confirming the feasi-
bility and the safety of the intervention also in asymp-
tomatic females. The use of patch in females did not
affect perioperative results, which were similar to those
obtained when a primary closure or an eversion tech-
nique was used, suggesting the effectiveness of our policy
of wide placement of patch with selective use of alterna-
tive arterial reconstruction.
We also found the presence of diabetes and contralateral
occlusion to significantly affect the long-term risk of ipsilateral
neurological events in females, but not in males, confirming
the role of these comorbidities in defining the safety ofCEA in
women.This is in our opinion an interesting finding, primarily
because of the lack of data in the literature concerning factorsaffecting late risk of ipsilateral stroke in particular subgroups of
patients like females.
Our policy of an extensive use of patch closure may
explain why patch closure rates in our study were similar
between women and men (79% and 74% respectively);
however, women were less likely to have a primary closure
performed because of increased utilization of an eversion
technique in women. Estimated freedom from severe reste-
nosis at 48 months was also similar between women and
men (93.8% and 96% respectively).
Despite the intrinsic limits of a non-randomized, retro-
spective study with a large number of cases but with a
relatively small number of events, particularly in the setting
of females with contralateral occlusion, our analysis allowed
us to identify a subgroup of female patients with a higher
percentage of early and late complications, who should be
carefully examined and counselled before surgical interven-
tion is suggested. Theoretically, the presence of contra-
lateral occlusion and/or diabetes in female patients who are
candidates for CEA could represent an indication for alter-
native management, such as endovascular surgery, but also
nonoperative treatment. However, there is little data avail-
able concerning the influence of gender on the results of
carotid artery stenting (CAS),24,25 there is no compelling
evidence to suggest that one treatment technique might be
more beneficial in men or women, and there is a lack of
analysis of natural history of nonoperated carotid stenosis in
particular subgroups of patients potentially at higher surgi-
cal risk.26 For this reason, future studies with long-term
follow-up comparing CEA, CAS, and medical treatment
alone in specific high-risk subgroups of patients are war-
ranted.
CONCLUSIONS
In our experience female sex per se does not represent
an adjunctive risk factor during CEA, with excellent early
and long term results, comparable to those obtained in
male patients. Female patients with contralateral occlusion
or diabetes in our experience had worse perioperative re-
sults. Whether they represent a high risk subgroup requir-
ing careful preoperative patient selection and counseling, it
should be confirmed by further studies.
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Dr Ali AbuRahma (Charleston, WV). It was not clear to me
how many of the female patients were patched; and for the ones
who were not patched, did you notice any difference in the
perioperative stroke rates?
Dr Walter Dorigo. Female patients underwent patching in
more than 75% of the cases. And when we analyzed our results
comparing the use of patch or no patch in female patients, we had
similar perioperative outcomes between the two groups. The
choice not to patch a female patient is made on the basis of
anatomical criteria, diameter of internal carotid artery, and the
presence of distal tortuosity and kinking, and in that case we use an
eversion technique.
Dr AbuRahma. Did you measure the internal carotid artery
(ICA) diameter in surgery, or did you compare males and females
with the same size ICA?
Dr Dorigo. We don’t routinely measure the internal carotid
artery during intervention. We have been probably pushed toward
an extensive use of patch in female patients due also to the dataDr Robert Zwolak (Lebanon, NH). This is a very large
experience. Have your results actually changed how you and your
partners choose your female patients?
DrDorigo.Not at themoment. But probably in the future we
will be more cautious in treating some subgroups of patients.
Probably an asymptomatic female patient with diabetes and con-
tralateral occlusion could be better managed also with medical
treatment. We’re waiting for data of stenting in this subgroup.
Dr Firas Mussa (New York, NY). How many of those pa-
tients were symptomatic? And of those who were symptomatic,
how many had acute neurological deficit?
Dr Dorigo. From this series, urgent interventions for acute
neurological symptoms were excluded. Concerning the influence
of preoperative symptoms, we analyzed the role of symptoms in
female patients and we found that in symptomatic patients only
contralateral occlusion affects the results, while in asymptomatic
patients only diabetes. But again, you have to consider that female
patients with contralateral occlusion are 45 patients out of 1,200,
so the results are not conclusive.
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Volume 50, Number 6 Dorigo et al 1307DrKumudRai (NewDelhi, India). Your conclusion is based on
only nine patients that you had, and out ofwhich one died. Iwouldn’t
read too much into it because the numbers are very small. To state
that diabetes and contralateral occlusion are high-risk factors, based
on just nine patients, to my mind is not a very valid observation.
Dr Dorigo. I agree with you. But you have to consider that
the largest monocentric published series of carotid endarterecto-
mies in female patients is that from the Cleveland Clinic, including
1,100 interventions and only a few numbers with contralateralpatients we should have at least a double number of females and
double number of males, so at least 10,000 interventions. And we
are not able at the moment to provide these numbers.
Dr James DeBord (Peoria, Ill). Was there any difference in
your patients who were on hormone replacement therapy versus
those who were not?
Dr Dorigo. There are interesting papers also in the Journal
concerning the effect of hormone replacement in females under-
going carotid endarterectomy, but we didn’t have these data at theocclusion. So I agree with you. But to have a larger number of time of inclusion into the database.
